| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Federated Hermes Global Investment Management Corp.
|
5.114m | 10.83% | +934.000 | Apr 09 2026 |
| 2 |
Balyasny Asset Management LP
|
4.257m | 9.01% | -1.600k | Apr 09 2026 |
| 3 |
Janus Henderson Investors
|
4.257m | 9.01% | -37.259k | Apr 09 2026 |
| 4 |
Vivo Capital, LLC
|
3.863m | 8.18% | -459.756k | Apr 09 2026 |
| 5 |
Logos Global Management LP
|
3.311m | 7.01% | +96.000k | Apr 09 2026 |
|
1
Federated Hermes Global Investment Management Corp.
|
10.83%
5.114m
|
|
2
Balyasny Asset Management LP
|
9.01%
4.257m
|
|
3
Janus Henderson Investors
|
9.01%
4.257m
|
|
4
Vivo Capital, LLC
|
8.18%
3.863m
|
|
5
Logos Global Management LP
|
7.01%
3.311m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 44.04% of Minerva Neurosciences Inc, with Federated Hermes Global Investment Management Corp. the biggest at 10.83%, followed by Balyasny Asset Management LP (9.01%) and Janus Henderson Investors (9.01%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Minerva Neurosciences Inc has risen over the past 12 months from around 0.9% to 5.3% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


